Modeling the Case for Injectable Contraceptive Manufacturing in sub-Saharan Africa

The injectable contraceptive market in sub-Saharan Africa (SSA) is dominated by imports from only a few manufacturers. Such market concentration makes the supply of modern contraceptives to SSA potentially vulnerable to disruptions to the supply chain. In FY21, IQVIA, under the USAID Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project, conducted a preliminary assessment of the profitability of locating hormonal contraceptive manufacturing in SSA, which indicated that there may be a business case for the manufacture of injectables contraceptives in the region. In FY22, the team further explored the potential for local manufacturing injectable contraceptives by assessing the demand in both FP2030 SSA and South Africa markets, and updating the model developed in FY21 to account for revised assumptions and costs. Please join us on January 18, 2023 at 9am EST for a presentation by IQVIA Director for Healthcare Stakeholders Dr. Peter Stephens who will share findings from this latest analysis.